Cardiogenic Shock and Cardiac Arrest State-of-the-Art: Risk Scores and Evidence-Based Management

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Abiomed; Chiesi
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Abiomed; Cardiovascular Systems Inc; Zoll; Procyrion